Pamela Goodwin, MD: Metformin and Breast Cancer
Description: Dr. Pamela Goodwin discusses the current findings in her ongoing clinical trial looking at the use of metformin (a generic diabetes drug) in patients with breast cancer at the American Association for Cancer Research (AACR) Annual 2012 meeting in Chicago.
Pamela Goodwin, MD is a Senior Investigator at the Samuel Lunenfeld
Research Institute, Mount Sinai Hospital, Joseph & Wolf Lebovic Health Complex in Toronto, Canada. Dr. Goodwin has focused her research activities in the area of breast cancer. She has a longstanding interest in the role of obesity and nutrition-related factors in breast cancer development and recurrence. Dr. Goodwin has recently turned her attention to research into strategies to reduce the impact of obesity and other lifestyle factors on breast cancer outcomes, focusing on weight loss and the potential impact of metformin, an insulin lowering drug commonly used to treat diabetes, on breast cancer outcomes.
Shared By : vitaloptions
Posted on : 05/17/12
Added : 5 years ago